Mei-Sheng Tai

Title: Innovations by Mei-Sheng Tai

Introduction

Mei-Sheng Tai is a prominent inventor based in Shrewsbury, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of modified proteins. With a total of 3 patents to her name, her work has the potential to impact therapeutic applications significantly.

Latest Patents

Mei-Sheng Tai's latest patents include innovative inventions related to the TGF-β superfamily proteins. One of her notable inventions provides modified TGF-β family proteins that possess altered biological or biochemical properties. This invention outlines methods for creating these proteins, which include constructs such as N-terminal truncations, 'latent' proteins, fusion proteins, and heterodimers. Another significant patent focuses on modified proteins and DNAs of the TGF-β superfamily, including morphogenic proteins. These modified proteins are designed through the manipulation or exchange of subdomains among various members of the superfamily, allowing for the mixing and matching of desired attributes for therapeutic exploitation.

Career Highlights

Mei-Sheng Tai is currently employed at Stryker Corporation, where she continues to advance her research and innovations. Her work at Stryker has positioned her as a key player in the biotechnology sector, contributing to the development of cutting-edge medical technologies.

Collaborations

Throughout her career, Mei-Sheng Tai has collaborated with esteemed colleagues, including Hermann Oppermann and John McCartney. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Mei-Sheng Tai's contributions to the field of biotechnology through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in therapeutic applications, showcasing the importance of innovation in science.